Summary

Hemoglobin A1c Testing Devices Market – Scope of Report
TMR’s report on the global hemoglobin A1c testing devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hemoglobin A1c testing devices market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemoglobin A1c testing devices market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hemoglobin A1c testing devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hemoglobin A1c testing devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hemoglobin A1c testing devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hemoglobin A1c testing devices market.

The report delves into the competitive landscape of the global hemoglobin A1c testing devices market. Key players operating in the global hemoglobin A1c testing devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hemoglobin A1c testing devices market profiled in this report.

Key Questions Answered in Global hemoglobin A1c testing devices Market Report
• What is the sales/revenue generated by hemoglobin A1c testing devices across all regions during the forecast period?
• What are the opportunities in the global hemoglobin A1c testing devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Hemoglobin A1c Testing Devices Market – Research Objectives and Research Approach
The comprehensive report on the global hemoglobin A1c testing devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hemoglobin A1c testing devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hemoglobin A1c testing devices market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemoglobin A1c Testing Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. PESTEL Analysis
5.2. Regulatory Scenario by Region/Country
5.3. PORTER’s Five Forces Analysis
5.4. Product/Brand Analysis of Haemoglobin A1c Testing Devices
5.5. Technological Advancement
5.6. Incidence and Prevalence Rate of Diabetes
6. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2020-2034
6.3.1. Cation-exchange Chromatography
6.3.2. Immunoassay
6.3.3. Boronate Affinity Chromatography
6.3.4. Others (Enzymatic assay, etc.)
6.4. Market Attractiveness Analysis, by Technology
7. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Modality
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Modality, 2020-2034
7.3.1. Automated
7.3.2. Semi-automated
7.4. Market Attractiveness Analysis, by Modality
8. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Ambulatory Surgical Centres
8.3.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Hemoglobin A1c Testing Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Technology, 2020-2034
10.2.1. Cation-exchange Chromatography
10.2.2. Immunoassay
10.2.3. Boronate Affinity Chromatography
10.2.4. Others (Enzymatic assay, etc.)
10.3. Market Value Forecast, by Modality, 2020-2034
10.3.1. Automated
10.3.2. Semi-automated
10.4. Market Value Forecast, by End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Ambulatory Surgical Centres
10.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
10.5. Market Value Forecast, by Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By Modality
10.6.3. By End-user
10.6.4. By Country
11. Europe Hemoglobin A1c Testing Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2020-2034
11.2.1. Cation-exchange Chromatography
11.2.2. Immunoassay
11.2.3. Boronate Affinity Chromatography
11.2.4. Others (Enzymatic assay, etc.)
11.3. Market Value Forecast, by Modality, 2020-2034
11.3.1. Automated
11.3.2. Semi-automated
11.4. Market Value Forecast, by End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Ambulatory Surgical Centres
11.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Technology
11.6.2. By Modality
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Hemoglobin A1c Testing Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2020-2034
12.2.1. Cation-exchange Chromatography
12.2.2. Immunoassay
12.2.3. Boronate Affinity Chromatography
12.2.4. Others (Enzymatic assay, etc.)
12.3. Market Value Forecast, by Modality, 2020-2034
12.3.1. Automated
12.3.2. Semi-automated
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Ambulatory Surgical Centres
12.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By Modality
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Hemoglobin A1c Testing Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2020-2034
13.2.1. Cation-exchange Chromatography
13.2.2. Immunoassay
13.2.3. Boronate Affinity Chromatography
13.2.4. Others (Enzymatic assay, etc.)
13.3. Market Value Forecast, by Modality, 2020-2034
13.3.1. Automated
13.3.2. Semi-automated
13.4. Market Value Forecast, by End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Ambulatory Surgical Centres
13.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By Modality
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Hemoglobin A1c Testing Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technology, 2020-2034
14.2.1. Cation-exchange Chromatography
14.2.2. Immunoassay
14.2.3. Boronate Affinity Chromatography
14.2.4. Others (Enzymatic assay, etc.)
14.3. Market Value Forecast, by Modality, 2020-2034
14.3.1. Automated
14.3.2. Semi-automated
14.4. Market Value Forecast, by End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Ambulatory Surgical Centres
14.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
14.5. Market Value Forecast, by Country/Sub-region, 2020-2034
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Technology
14.6.2. By Modality
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Alere Technologies AS (Abbott)
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. GC Medical Science Corp.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Osang Healthcare Co., Ltd
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. EKF Diagnostics Holdings
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Boditech Med Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Eurolyser Diagnostica GmbH
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Bayer AG
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Siemens Healthineers
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Other Prominent Players
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview